市場調査レポート

商品コード

1370351

喘息治療薬市場：世界の産業動向、シェア、市場規模、成長、機会、2023-2028年予測

Asthma Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日: 2023年10月15日 | 発行: IMARC

| ページ情報: 英文 150 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF & Excel (Single User License)

USD 2,499 391,743円

レポートPDFおよびExcelを1名のみがご利用頂けるライセンスです。PDFおよびExcelの印刷は一度のみ可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (5 User License)

USD 3,499 548,503円

レポートPDFおよびExcelを同一企業内の5名様までがご利用頂けるライセンスです。PDFおよびExcelの印刷は可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Corporate License)

USD 4,499 705,263円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等の編集は可能ですが、事前にIMARC Services Private Limited社の許可が必要です。PDFおよびExcelの印刷回数に制限はありません。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

概要

市場概要 2023-2028年

世界の喘息治療薬市場規模は2022年に181億米ドルに達しました。今後、IMARC Groupは、2023年から2028年にかけて2.34%の成長率（CAGR）を示し、2028年までに206億米ドルに達すると予測しています。

喘息治療薬は、喘息の治療に使用される様々な医薬品を指します。喘息は通常、汚染、アレルゲン、埃などの屋内外の原因物質によって引き起こされます。これらの治療薬は通常、気管支拡張薬と抗炎症薬であり、コルチコステロイド、長時間作用性β作動薬（LABA）、メチルキサンチン、免疫調節薬、ロイコトリエン調節薬などが含まれます。吸入、注射、経口投与が可能な多くの併用療法薬も使用されます。これらの薬剤は肺への通路を広げ、空気の移動を可能にして呼吸を改善します。また、肺の粘液を取り除き、咳き込みやすくする効果もあります。

喘息治療薬の市場動向：

喘息やその他の呼吸器疾患の有病率の増加と診断技術の向上は、市場の成長を促進する重要な要因の1つです。さらに、効果的な喘息治療薬の入手可能性に関する大衆の意識の高まりも、市場成長を後押ししています。例えば、喘息患者は主に吸入コルチコステロイド薬で治療され、進行した状態や持続性の喘息患者は標的特異的薬剤で治療されます。また、免疫グロブリンEや特定のサイトカインをブロックするモノクローナル抗体（mAbs）の需要も拡大しています。呼吸器疾患治療のための併用療法の開発は、もう一つの成長促進要因として作用しています。ヘルスケア支出の増加、医学分野における広範な研究開発（R&D）活動、医療インフラの改善は、市場をさらに牽引すると期待されるその他の要因の一部です。

本レポートで扱う主な質問

2022年の世界の喘息治療薬市場規模は？
2023～2028年の世界の喘息治療薬市場の予想成長率は？
世界の喘息治療薬市場を牽引する主な要因は？
COVID-19が世界の喘息治療薬市場に与えた影響は？
喘息治療薬の世界市場における薬剤クラス別内訳は？
製品タイプに基づく世界の喘息治療薬市場の内訳は？
治療タイプに基づく喘息治療薬の世界市場内訳は？
投与経路に基づく世界の喘息治療薬市場の内訳は？
喘息治療薬の世界市場における主要地域は？
世界の喘息治療薬市場における主要プレーヤー/企業は？

吸入薬
- 市場動向
- 主要タイプ
  - ドライパウダー吸入器
  - 定量吸入器
  - ソフトミスト吸入器
- 市場予測
ネブライザー
- 市場動向
- 主な種類
  - 空気圧式ネブライザー
  - 超音波ネブライザー
  - メッシュ式ネブライザー
- 市場予測

第8章市場内訳：治療タイプ別

即効薬
- 市場動向
- 市場予測
長期喘息治療薬
- 市場動向
- 市場予測

第9章市場内訳：投与経路別

吸入
- 市場動向
- 市場予測
経口
- 市場動向
- 市場予測
非経口
- 市場動向
- 市場予測

第10章市場内訳：地域別

北米
- 米国
  - 市場動向
  - 市場予測
- カナダ
  - 市場動向
  - 市場予測
アジア太平洋
- 中国
  - 市場動向
  - 市場予測
- 日本
  - 市場動向
  - 市場予測
- インド
  - 市場動向
  - 市場予測
- 韓国
  - 市場動向
  - 市場予測
- オーストラリア
  - 市場動向
  - 市場予測
- インドネシア
  - 市場動向
  - 市場予測
- その他
  - 市場動向
  - 市場予測
欧州
- ドイツ
  - 市場動向
  - 市場予測
- フランス
  - 市場動向
  - 市場予測
- 英国
  - 市場動向
  - 市場予測
- イタリア
  - 市場動向
  - 市場予測
- スペイン
  - 市場動向
  - 市場予測
- ロシア
  - 市場動向
  - 市場予測
- その他
  - 市場動向
  - 市場予測
ラテンアメリカ
- ブラジル
  - 市場動向
  - 市場予測
- メキシコ
  - 市場動向
  - 市場予測
- その他
  - 市場動向
  - 市場予測
中東・アフリカ地域
- 市場動向
- 市場内訳：国別
- 市場予測

第11章 SWOT分析

概要
強み
弱み
機会
脅威

第12章バリューチェーン分析

第13章ポーターのファイブフォース分析

概要
買い手の交渉力
供給企業の交渉力
競合の程度
新規参入業者の脅威
代替品の脅威

第14章価格分析

第15章競合情勢

市場構造
主要企業
主要企業のプロファイル
- AstraZeneca PLC
- Abbott Laboratories
- Amgen Inc.
- Biogen Inc.
- Boehringer Ingelheim International GmbH
- F. Hoffmann-La Roche Ltd.
- GlaxoSmithKline Plc
- Merck Sharp & Dohme Corp.
- Novartis International AG
- Sunovion Pharmaceuticals Inc.
- Teva Pharmaceutical Industries Ltd.

図表

List of Figures

Figure 1: Global: Asthma Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Asthma Therapeutics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Asthma Therapeutics Market: Breakup by Drug Class (in %), 2022
Figure 4: Global: Asthma Therapeutics Market: Breakup by Product Type (in %), 2022
Figure 5: Global: Asthma Therapeutics Market: Breakup by Treatment Type (in %), 2022
Figure 6: Global: Asthma Therapeutics Market: Breakup by Route of Administration (in %), 2022
Figure 7: Global: Asthma Therapeutics Market: Breakup by Region (in %), 2022
Figure 8: Global: Asthma Therapeutics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 9: Global: Asthma Therapeutics (Anti-Inflammatory Drugs) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Asthma Therapeutics (Anti-Inflammatory Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Asthma Therapeutics (Bronchodilators) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Asthma Therapeutics (Bronchodilators) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Asthma Therapeutics (Combination Therapies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Asthma Therapeutics (Combination Therapies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Asthma Therapeutics (Inhalers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Asthma Therapeutics (Inhalers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Asthma Therapeutics (Nebulizers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Asthma Therapeutics (Nebulizers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Asthma Therapeutics (Quick-Relief Medications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Asthma Therapeutics (Quick-Relief Medications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Asthma Therapeutics (Long-Term Asthma Control Medications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Asthma Therapeutics (Long-Term Asthma Control Medications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Asthma Therapeutics (Inhalation) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Asthma Therapeutics (Inhalation) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Asthma Therapeutics (Oral) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Asthma Therapeutics (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Asthma Therapeutics (Parenteral) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Asthma Therapeutics (Parenteral) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: North America: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: North America: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: United States: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: United States: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Canada: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Canada: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Asia Pacific: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Asia Pacific: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: China: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: China: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Japan: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Japan: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: India: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: India: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: South Korea: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: South Korea: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Australia: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Australia: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Indonesia: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Indonesia: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Others: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Others: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Europe: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Europe: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Germany: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Germany: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: France: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: France: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: United Kingdom: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: United Kingdom: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Italy: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Italy: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Spain: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Spain: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Russia: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Russia: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Others: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Others: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Latin America: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Latin America: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Brazil: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Brazil: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Mexico: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Mexico: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Others: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Others: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Middle East and Africa: Asthma Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Middle East and Africa: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Global: Asthma Therapeutics Industry: SWOT Analysis
Figure 78: Global: Asthma Therapeutics Industry: Value Chain Analysis
Figure 79: Global: Asthma Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Asthma Therapeutics Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Asthma Therapeutics Market Forecast: Breakup by Drug Class (in Million US$), 2023-2028
Table 3: Global: Asthma Therapeutics Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
Table 4: Global: Asthma Therapeutics Market Forecast: Breakup by Treatment Type (in Million US$), 2023-2028
Table 5: Global: Asthma Therapeutics Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
Table 6: Global: Asthma Therapeutics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Asthma Therapeutics Market Structure
Table 8: Global: Asthma Therapeutics Market: Key Players

Product Code: SR112023A2338

Abstract

Market Overview 2023-2028:

The global asthma therapeutics market size reached US$ 18.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 20.6 Billion by 2028, exhibiting a growth rate (CAGR) of 2.34% during 2023-2028.

Asthma therapeutics refer to various pharmaceutical drugs that are used for the treatment of asthma. Asthma is usually triggered by indoor and outdoor causative agents, including pollution, allergens and dust. These therapeutics are usually bronchodilators and anti-inflammatory drugs, which include corticosteroids, long-acting beta-agonists (LABA), methylxanthine, immunomodulators and leukotriene modifiers. A number of combination therapy drugs are also used that can be inhaled, injected, or orally administered. These drugs expand the passageway into the lungs and enable the movement of air to improve breathing. They also aid in clearing mucus from the lungs that gets coughed out with ease.

Asthma Therapeutics Market Trends:

The increasing prevalence of asthma and other respiratory disorders, along with improvements in the diagnostic technologies, is one of the key factors driving the growth of the market. Furthermore, rising awareness among the masses regarding the availability of effective asthma therapeutics is also providing driving the market growth. For instance, asthmatic patients are primarily treated with inhaled corticosteroids and patients with advanced conditions or persistent asthma are treated with target-specific drugs. There is also an extensive demand for monoclonal antibodies (mAbs) that block immunoglobulin E and specific cytokines. The development of combination therapies for the treatment of respiratory diseases is acting as another growth-inducing factor. Increasing healthcare expenditures, extensive research, and development (R&D) activities in the field of medical sciences and improvements in the healthcare infrastructure are some of the other factors that are expected to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global asthma therapeutics market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on drug class, product type, treatment type and route of administration.

Breakup by Drug Class:

Anti-Inflammatory Drugs

Bronchodilators

Combination Therapies

Breakup by Product Type:

Inhalers

Dry Powder Inhalers

Metered Dose Inhalers

Soft Mist Inhalers

Nebulizers

Pneumatic Nebulizers

Ultrasonic Nebulizers

Mesh Nebulizers

Breakup by Treatment Type:

Quick-Relief Medications

Long-Term Asthma Control Medications

Breakup by Route of Administration:

Inhalation

Oral

Parenteral

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being AstraZeneca PLC, Abbott Laboratories, Amgen Inc., Biogen Inc., Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Merck Sharp & Dohme Corp., Novartis International AG, Sunovion Pharmaceuticals Inc. and Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report

1. What was the size of the global asthma therapeutics market in 2022?
2. What is the expected growth rate of the global asthma therapeutics market during 2023-2028?
3. What are the key factors driving the global asthma therapeutics market?
4. What has been the impact of COVID-19 on the global asthma therapeutics market?
5. What is the breakup of the global asthma therapeutics market based on the drug class?
6. What is the breakup of the global asthma therapeutics market based on the product type?
7. What is the breakup of the global asthma therapeutics market based on the treatment type?
8. What is the breakup of the global asthma therapeutics market based on the route of administration?
9. What are the key regions in the global asthma therapeutics market?
10. Who are the key players/companies in the global asthma therapeutics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Asthma Therapeutics Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Drug Class

6.1 Anti-Inflammatory Drugs
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Bronchodilators
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Combination Therapies
- 6.3.1 Market Trends
- 6.3.2 Market Forecast

7 Market Breakup by Product Type

7.1 Inhalers
- 7.1.1 Market Trends
- 7.1.2 Major Types
  - 7.1.2.1 Dry Powder Inhalers
  - 7.1.2.2 Metered Dose Inhalers
  - 7.1.2.3 Soft Mist Inhalers
- 7.1.3 Market Forecast
7.2 Nebulizers
- 7.2.1 Market Trends
- 7.2.2 Major Types
  - 7.2.2.1 Pneumatic Nebulizers
  - 7.2.2.2 Ultrasonic Nebulizers
  - 7.2.2.3 Mesh Nebulizers
- 7.2.3 Market Forecast

8 Market Breakup by Treatment Type

8.1 Quick-Relief Medications
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Long-Term Asthma Control Medications
- 8.2.1 Market Trends
- 8.2.2 Market Forecast

9 Market Breakup by Route of Administration

9.1 Inhalation
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Oral
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Parenteral
- 9.3.1 Market Trends
- 9.3.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 AstraZeneca PLC
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
  - 15.3.1.3 Financials
  - 15.3.1.4 SWOT Analysis
- 15.3.2 Abbott Laboratories
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
  - 15.3.2.3 Financials
  - 15.3.2.4 SWOT Analysis
- 15.3.3 Amgen Inc.
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
  - 15.3.3.3 Financials
  - 15.3.3.4 SWOT Analysis
- 15.3.4 Biogen Inc.
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
  - 15.3.4.3 Financials
  - 15.3.4.4 SWOT Analysis
- 15.3.5 Boehringer Ingelheim International GmbH
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
- 15.3.6 F. Hoffmann-La Roche Ltd.
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
  - 15.3.6.3 SWOT Analysis
- 15.3.7 GlaxoSmithKline Plc
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
  - 15.3.7.3 Financials
  - 15.3.7.4 SWOT Analysis
- 15.3.8 Merck Sharp & Dohme Corp.
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
  - 15.3.8.3 Financials
  - 15.3.8.4 SWOT Analysis
- 15.3.9 Novartis International AG
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
  - 15.3.9.3 Financials
  - 15.3.9.4 SWOT Analysis
- 15.3.10 Sunovion Pharmaceuticals Inc.
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
  - 15.3.10.3 SWOT Analysis
- 15.3.11 Teva Pharmaceutical Industries Ltd.
  - 15.3.11.1 Company Overview
  - 15.3.11.2 Product Portfolio
  - 15.3.11.3 Financials
  - 15.3.11.4 SWOT Analysis

喘息治療薬市場：世界の産業動向、シェア、市場規模、成長、機会、2023-2028年予測

Asthma Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

概要

市場概要 2023-2028年

喘息治療薬の市場動向：

本レポートで扱う主な質問

目次

第1章 序文

第2章 調査範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 喘息治療薬の世界市場

第6章 市場内訳：薬剤クラス別

第7章 市場内訳：製品タイプ別

第8章 市場内訳：治療タイプ別

第9章 市場内訳：投与経路別

第10章 市場内訳：地域別

第11章 SWOT分析

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

第14章 価格分析

第15章 競合情勢

List of Figures

List of Tables

Abstract

Market Overview 2023-2028:

Asthma Therapeutics Market Trends:

Key Market Segmentation:

Breakup by Drug Class:

Breakup by Product Type:

Breakup by Treatment Type:

Breakup by Route of Administration:

Breakup by Region:

Competitive Landscape:

Key Questions Answered in This Report

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Asthma Therapeutics Market

6 Market Breakup by Drug Class

7 Market Breakup by Product Type

8 Market Breakup by Treatment Type

9 Market Breakup by Route of Administration

10 Market Breakup by Region

11 SWOT Analysis

12 Value Chain Analysis

13 Porters Five Forces Analysis

14 Price Analysis

15 Competitive Landscape

第1章序文

第2章調査範囲と調査手法

第3章エグゼクティブサマリー

第4章イントロダクション

第5章喘息治療薬の世界市場

第6章市場内訳：薬剤クラス別

第7章市場内訳：製品タイプ別

第8章市場内訳：治療タイプ別

第9章市場内訳：投与経路別

第10章市場内訳：地域別

第12章バリューチェーン分析

第13章ポーターのファイブフォース分析

第14章価格分析

第15章競合情勢